CMAX Clinical Research is one of Australia’s largest and most experienced independent early-phase clinical research organizations. Operating a state-of-the-art facility, CMAX specializes in Phase I and early-phase clinical trials for global pharmaceutical, biotechnology, and medical device sponsors, delivering high-quality, internationally compliant trial data under strict FDA, GxP, and HIPAA regulatory standards.